300 related articles for article (PubMed ID: 23777679)
1. Plasmapheresis as adjuvant therapy in Stevens-Johnson syndrome and hepatic encephalopathy.
Hung PC; Wang HS; Hsia SH; Wong AM
Brain Dev; 2014 Apr; 36(4):356-8. PubMed ID: 23777679
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Plasmapheresis vs Immunoglobulin as First Treatment After Ineffective Systemic Corticosteroid Therapy for Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Miyamoto Y; Ohbe H; Kumazawa R; Matsui H; Fushimi K; Yasunaga H; Ohta B
JAMA Dermatol; 2023 May; 159(5):481-487. PubMed ID: 36884227
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome/toxic epidermal necrolysis.
Baker MG; Cresce ND; Ameri M; Martin AA; Patterson JW; Kimpel DL
J Clin Rheumatol; 2014 Apr; 20(3):167-71. PubMed ID: 24662561
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin therapy for Stevens-Johnson syndrome.
Brett AS; Philips D; Lynn AW
South Med J; 2001 Mar; 94(3):342-3. PubMed ID: 11284525
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin therapy for children with Stevens-Johnson syndrome.
Morici MV; Galen WK; Shetty AK; Lebouef RP; Gouri TP; Cowan GS; Gedalia A
J Rheumatol; 2000 Oct; 27(10):2494-7. PubMed ID: 11036849
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
9. The management of toxic epidermal necrolysis.
Fernando SL
Australas J Dermatol; 2012 Aug; 53(3):165-71. PubMed ID: 22881464
[TBL] [Abstract][Full Text] [Related]
10. Case of Steven-Johnson Syndrome in a male with breast cancer secondary to docetaxel/cyclophosphamide therapy.
Jarrett B; Ghazala S; Chao J; Chaudhary S
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27852659
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
[TBL] [Abstract][Full Text] [Related]
12. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
13. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of toxic epidermal necrolysis using plasmapheresis: A prospective observational study.
Han F; Zhang J; Guo Q; Feng Y; Gao Y; Guo L; Hou Y; An J; Wang X; Yan B; Zheng Y; Song J; Li M; Wang G
J Crit Care; 2017 Dec; 42():65-68. PubMed ID: 28688239
[TBL] [Abstract][Full Text] [Related]
15. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
[TBL] [Abstract][Full Text] [Related]
16. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Koh MJ; Tay YK
Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z
Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
[TBL] [Abstract][Full Text] [Related]
18. Severe pneumonia caused by combined infection with Pneumocystis jiroveci, parainfluenza virus type 3, cytomegalovirus, and Aspergillus fumigatus in a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Lee T; Bae YJ; Park SK; Park HJ; Kim SH; Cho YS; Moon HB; Lee SO; Kim TB
Acta Derm Venereol; 2010 Nov; 90(6):625-9. PubMed ID: 21057748
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome.
Lin WL; Lin WC; Chang YC; Yang LC; Hung SI; Hong HS; Chung WH
Am J Clin Dermatol; 2009; 10(5):339-42. PubMed ID: 19658448
[TBL] [Abstract][Full Text] [Related]
20. Ethosuximide-induced Stevens-Johnson syndrome: Beneficial effect of early intervention with high-dose corticosteroid therapy.
Tachibana K; Hamada T; Tsuchiya H; Shibata T; Fujii K; Kobayashi K; Iwatsuki K
J Dermatol; 2018 May; 45(5):592-595. PubMed ID: 29430697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
